Helmholtz Munich and the University of Sydney have identified biological mechanisms that are shared across psychiatric ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. Popular depictions of schizophrenia often focus on visual ...

Schizophrenia is a complex mental health condition that affects perception, thought and emotions. This complexity is reflected in the individual manifestations of the disease: for some patients ...

Cobenfy Falls Short as Add-On Therapy for Schizophrenia Compared with placebo, xanomeline/trospium as an add-on to atypical antipsychotics has not reached the threshold for a statistically ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. Schizophrenia might be among the most intensely studied mental ...

People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...

The medication, Cobenfy, combines two drugs and is taken as a twice-daily pill. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with ...

FDA approves Cobenfy, a brand new type of schizophrenia drug : Short Wave For the past 70 years, schizophrenia treatments all targeted the same chemical: dopamine. While that works for some, it ...

The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of drug for the condition in more than 30 years. In contrast to ...